Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psyllium in hypercholesterolemia

E K Chan1, D J Schroeder

  • 1School of Pharmacy, University of California, San Francisco 94143, USA.

The Annals of Pharmacotherapy
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Nomogram to Estimate Locoregional Recurrence-Free Survival for Women With T1-2 N0 Breast Cancer Managed With or Without Postmastectomy Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2025
Same author

In the Era After the European Organisation for Research and Treatment of Cancer 'Boost' Study, is the Additional Radiotherapy to the Breast Tumour Bed Still Beneficial for Young Women?

Clinical oncology (Royal College of Radiologists (Great Britain))·2020
Same author

Laser assisted soldering: effects of hydration on solder-tissue adhesion.

Journal of biomedical optics·2012
Same author

Use of the Semipermeable Membrane Device as an in Situ Sampler of Waterborne Bioavailable PCDD and PCDF Residues at Sub-Parts-per-Quadrillion Concentrations.

Environmental science & technology·2011
Same author

Echelle efficiencies: theory and experiment; author's reply to comment.

Applied optics·2010
Same author

Echelle efficiencies: theory and experiment.

Applied optics·2010
Same journal

Association Between Prior PARP Inhibitor Maintenance Therapy and Myelosuppression During Subsequent Chemotherapy in Ovarian Cancer.

The Annals of pharmacotherapy·2026
Same journal

Prolonged Response to Nivolumab in Metastatic Vulvar Carcinoma: Should Immunotherapy be Continued and for How Long? A Debatable Issue!

The Annals of pharmacotherapy·2026
Same journal

Stability of Ceftazidime-Avibactam: Changes in Regulatory Information and Implications for Preparation.

The Annals of pharmacotherapy·2026
Same journal

Impact of Early Dose Adjustment of Piperacillin/Tazobactam on Mortality in Critically Ill Patients With Acute Kidney Injury: A Retrospective Multicenter Cohort Study.

The Annals of pharmacotherapy·2026
Same journal

Severe Phototoxic Skin Reaction Associated With Vandetanib: Implications for Pharmaceutical Care.

The Annals of pharmacotherapy·2026
Same journal

Efficacy and Safety of Oral PCSK9 Inhibitors in Adults With Hypercholesterolemia: An Updated Systematic Review and Meta-Analysis of RCTs.

The Annals of pharmacotherapy·2026
See all related articles

Psyllium fiber can modestly lower LDL cholesterol, but is not a substitute for statin drugs. It serves as a beneficial dietary supplement for individuals with mild hypercholesterolemia, particularly when combined with diet therapy.

Area of Science:

  • Cardiovascular Health
  • Nutritional Science
  • Pharmacology

Background:

  • Hypercholesterolemia poses a significant risk for coronary events.
  • Dietary interventions are primary for managing high cholesterol.
  • Conventional lipid-lowering drugs have substantial effects but potential side effects.

Purpose of the Study:

  • To evaluate the efficacy of psyllium in lowering cholesterol levels.
  • To compare psyllium's lipid-lowering effects with conventional antilipidemic agents.
  • To determine psyllium's role as an adjunct therapy in hypercholesterolemia management.

Main Methods:

  • Controlled study evaluating psyllium's impact on total and LDL cholesterol.
  • Comparison of psyllium's effects against lovastatin.

Related Experiment Videos

  • Assessment of psyllium's tolerability and compliance.

    • Main Results:

    • Psyllium demonstrated a 4-8% reduction in total cholesterol and 6-13% in LDL cholesterol.
    • These effects are minimal compared to lovastatin (30% total cholesterol, 40% LDL cholesterol reduction).
    • Psyllium is well-tolerated with minor transient side effects and high compliance (>90%).

    Conclusions:

    • Psyllium is not recommended as drug therapy for moderate-to-severe hypercholesterolemia.
    • Psyllium can be a useful adjunct to AHA step 1 diet therapy for low-risk individuals.
    • Further research is needed on psyllium's effects in women and long-term efficacy.